Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial

Title
Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial
Authors
Keywords
Aprepitant, Pediatric cancer, Anti-emetics
Journal
SUPPORTIVE CARE IN CANCER
Volume 23, Issue 11, Pages 3229-3237
Publisher
Springer Nature
Online
2015-04-07
DOI
10.1007/s00520-015-2714-9

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now